(Reuters) -HistoSonics, a medical technology company backed by Johnson & Johnson, is exploring a potential sale after receiving multiple takeover approaches, the Financial Times reported on Friday,
HistoSonics Considers $2.5 Billion Sale Amid Interest
(Reuters) -HistoSonics, a medical technology company backed by Johnson & Johnson, is exploring a potential sale after receiving multiple takeover approaches, the Financial Times reported on Friday, citing people familiar with the matter.
The company is seeking a valuation of more than $2.5 billion, the report said.
(Reporting by Bipasha Dey in Bengaluru; Editing by Sonia Cheema)





